Mode
Text Size
Log in / Sign up
N/A Completed N=2,014

Attain Success Clinical Trial

Source: ClinicalTrials.gov NCT00990964 ↗
Enrolled (actual)
2,014
Serious AEs
2.7%
Results posted
Sep 2012
Primary outcomePrimary: Subjects Successfully Implanted With an Attain Family Left-heart Lead Using an Attain Family Delivery Catheter — 1802 participants

Summary

The purpose of the study is to assess lead implant success and complication rate using the Medtronic Attain Family of left-heart leads and delivery catheters.

Outcome Measures

OutcomeResultp-value
PRIMARY
Subjects Successfully Implanted With an Attain Family Left-heart Lead Using an Attain Family Delivery Catheter
1802 —
PRIMARY
Subjects Without a Left-heart Lead and Delivery Catheter Related Complication
1895 —

Eligibility Criteria

Inclusion Criteria

  • Subject is at least 18 years of age or older
  • Subject will be implanted with Medtronic cardiac resynchronization therapy (CRT) device and Medtronic left heart lead utilizing (or attempting to utilize) Attain Family of delivery catheters. The implant procedure may include upgrades to CRT from implantable pulse generator (IPG) or implantable cardioverter-defibrillator (ICD).

Exclusion Criteria

  • Subject is enrolled in a concurrent study with the exception of a study approved by the Medtronic Clinical Trial Leader prior to enrollment
  • Subject has existing CRT system implanted or was previously implanted with a CRT system.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00990964). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search